We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

What This Top Dividend Portfolio Is Holding Now: Royal Dutch Shell Plc, GlaxoSmithKline plc and HSBC Holdings plc

Royal Dutch Shell Plc (LON:RDSB), GlaxoSmithKline plc (LON:GSK) and HSBC Holdings plc (LON:HSBA) are the heavyweight holdings of Merchants Trust (LON:MRCH).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

HSBC

Merchants Trust (LSE: MRCH) is on track to deliver 31 straight years of dividend increases.  The prospective yield is 4.6% at a recent share price of 516p. Picking great dividend shares has helped Merchants outperform the FTSE All-Share Index over the past three, five and 10 years.

XXX

Let’s take a look at the trust’s current top three holdings: Royal Dutch Shell (LSE: RDSB), GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and HSBC (LSE: HSBA).

Royal Dutch Shell

The shares of oil titan Royal Dutch Shell are trading close to a 52-week high, having put on a bit of a spurt since the company announced its annual results on 30 January.

New boss Ben van Beurden, said that after Shell’s heavy investment for growth in recent years, “2014 will be a year where we are changing emphasis, to improve our returns and cash flow performance”. The new focus is good news for shareholders’ dividends.

The board raised the 2013 payout (declared in US dollars) by 4.7%, and early indications suggest a rise of 4.4% for 2014. The consensus forecast for the sterling dividend is 114p, giving a prospective income of 4.8% at a recent share price of 2,365p — well ahead of the market average yield of 3.1%.

GlaxoSmithKline

Pharmaceuticals group GlaxoSmithKline (GSK) is another global giant currently offering a dividend yield well above the market average.

GSK reported core earnings-per-share (EPS) growth of 4% on turnover growth of 1% when announcing its annual results earlier this month. The board guided for accelerating growth in 2014, saying it expects turnover to rise by 2% and EPS by 4%-8%.

The company increased the 2013 dividend by 5.4%, and analysts are forecasting a 5.1% rise to 82p this year. That represents a prospective yield of 4.9% at a recent share price of 1,680p.

HSBC

Concerns about slowing growth in many emerging markets have weighed on companies with high exposure to these economies. The shares of HSBC (originally the Hong Kong and Shanghai Banking Company), with its big presence in Asia, are currently trading close to a 52-week low.

The company posted a 9% rise in profits for 2013 in results announced this week, but that fell a bit short of market expectations. However, chief executive Stuart Gulliver said three years of restructuring and cost-cutting had made the group “leaner and simpler … with strong potential for growth”. The board upped the dividend (declared in US dollars) by 8.9%, with the chief exec saying: “Strong capital generation continues to support our progressive dividend policy”.

HSBC has said it intends to maintain the first three quarterly dividends for this year at the same level as 2013. Even a de minimis increase in the final dividend, to maintain the progressive dividend policy, would see a $0.50 payout for the year — about 31p at current exchange rates, giving a prospective income of around 5% at a recent share price of 628p

> G A Chester does not own any shares mentioned in this article. The Motley Fool has recommended shares in GlaxoSmithKline.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »